NK-3

CAT # Izina ryibicuruzwa Ibisobanuro
CPD100768 Fezolinetant Fezolinetant, izwi kandi ku izina rya ESN-364, ni Neurokinin-3 (NK-3) reseptor antagonist yakiriwe neza kugira ngo ikoreshwe mu buzima bw’umugore, kandi ikaba irimo gutezwa imbere kubera indwara ziterwa n’imibonano mpuzabitsina nka endometriose, syndrome ya polycystic ovarian na fibroide ya nyababyeyi. . Fexolinetant yemerera guhindura hypothalamic-pituitar gonadal axis hamwe nigikorwa cyo guhitamo imisemburo ifitanye isano n'indwara. Biteganijwe ko umukozi ashobora kwihanganira ibicuruzwa birushanwe byibasira GnRH (imisemburo ya Gonadotropine).
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!